Today on Pharmaceutical Processing
Festo introduces smart pipette for automated dispensing systems
The German industrial control and automation firm Festo has introduced its DHOP closed-loop smart-pipette for automated, high-speed dispensing systems used for pharmaceutical, biotech and cosmetic R&D. The Esslingen, Germany-based company announced the pipette at the Interphex tradeshow scheduled for May 24-26 in New York City. The DHOP pipette will formally be available in mid-2022. Festo…
GlaxoSmithKline officially rebrands as GSK
GlaxoSmithKline (NYSE:GSK) has long gone by its acronym GSK. Now, the abbreviation is the company’s official name. GlaxoSmithKline had announced its plan to change the name in an earnings announcement in April 27. The London Stock Exchange and the New York Stock Exchange will update the company’s name in “due course,” as the company explained in…
Sponsored Content See More >
A new way to access scientific papers?Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA AssaysBy Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing…
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
The FDA has decided to limit the use of the COVID-19 vaccine to individuals at least 18 years old who cannot receive other authorized or approved COVID-19 vaccines. The agency also will authorize its use for individuals who would “otherwise not receive a COVID-19 vaccine.” FDA came to the conclusion after reviewing data related to…
Facility See More >
How Target Value Delivery can help keep pharma construction projects on track
New plant construction in the pharmaceutical industry frequently exceeds the allocated budget and runs over the expected time, contributing to the industry’s challenge to increase drug output over the past decade. Consulting firm Turner & Townsend estimates that some 70% of pharma construction projects miss their original budget by about 15%. Though the pandemic’s impact on…
Supply Chain See More >
NIH starts evaluating second COVID-19 booster shots in adults
The NIH recently announced that it has started enrolling adults for a Phase 2 clinical trial evaluating various additional COVID-19 booster shots. NIH’s National Institute of Allergy and Infectious Diseases (NIAID) is sponsoring the COVID-19 Variant Immunologic Landscape (COVAIL) trial. “We are looking beyond the Omicron variant to determine the best strategy to protect against…
Recalls See More >
Novartis temporarily halts production of two radioligand therapy medicines
Novartis (NYSE:NVS) announced that it had voluntarily stopped the production at radioligand therapy plants in Ivrea, Italy and Millburn, New Jersey, over possible quality concerns. In a statement, the company explained it had made the decision “out of an abundance of caution due to potential quality issues identified in its manufacturing processes.” As a result,…
